In the fast-paced world of biopharmaceuticals, navigating the complex maze of microbiology testing solutions can make or break the path to market success. The team at Charles River understands that the road from breakthrough to market-ready product is precarious because of stringent budget constraints and test capacity limitations.
With fewer than one percent of drug candidates making it through clinical trials, choosing the right microbiology testing partner is crucial. Charles River stands out as that trusted ally, equipped with a proven track record for quality and leading scientific testing solutions.
With over 40,000 tests conducted yearly across our global biologics testing facilities and support for more than 200 products, Charles River handles a wide array of testing needs. They specialize in monoclonal antibodies, recombinant proteins, viral vectors, vaccines, and cell therapies. Biotech, pharmaceutical manufacturers, and health facilities can rely on Charles River to ensure the biologic is safe, effective, and meets all regulatory requirements.
